MARKET RADAR
SENSEX     NIFTY      
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 17, 17:00
448.05
0
VOLUME 104,186
LIVE
NSE
Feb 17, 17:00
448.60
0
VOLUME 659,121
Management Interviews on Ranbaxy Laboratories
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Ranbaxy to have 30% mkt share for Lipitor: PharmAsiaNews 

8.56 am | 01 Dec 2011 |  Source: CNBC-TV18

Vikas Dandekar of PharmAsiaNews.com tells CNBC-TV18 that the US FDA approval for Lipitor is definitely going to be a big positive for Ranbaxy....

Lipitor is biggest catalyst to Ranbaxy's growth: Expert 

11.55 am | 30 Nov 2011 |  Source: CNBC-TV18

Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that Ranbaxy is most likely set to go ahead with the launch of the generic ...

1
Quick Links for Ranbaxy Laboratories
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.